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total 5 deaths were reported in the study period. Taking into 
account different world economies, there were no differ-
ences in the complication rates between the developing and 
developed nations or between different centres from differ-
ent continents.
Conclusion Ureterorenoscopy is a safe and effective pro-
cedure for treatment of stones, the outcomes of which are 
broadly comparable in different parts of the world for simi-
lar patient and stone demographics.
Keywords Ureterorenoscopy · Complications · Clavien–
Dindo · Urolithiasis
Abbreviations
AMI  Acute myocardial infarction
CRF  Case report form
CROES  Clinical Research Office of Endourological 
Society
CVA  Cerebro-vascular accident
CVD  Cardiovascular disease
DM  Diabetes mellitus
EHL  Electro-hydraulic lithotripsy
LOHS  Length of hospital stay
PNL  Percutaneous nephrolithotomy
SFR  Stone-free rate
SWL  Shockwave lithotripsy
URS  Ureterorenoscopy
US  Ultrasound
UTI  Urinary tract infection
Introduction
Ureterorenoscopy (URS) is used for management of urolithi-
asis and is often preferred due to its higher stone-free rate 
Abstract 
Introduction Ureterorenoscopy (URS) is a popular and 
growing option for management of ureteric and renal 
stones. The CROES URS Global Study was set up to 
assess the outcomes of URS in a large worldwide cohort of 
patients involving multiple centres. In this paper, we ana-
lysed the database for intra-operative and post-operative 
complications associated with ureterorenoscopy.
Methods The CROES database was established via col-
laboration between 114 centres in 32 countries worldwide, 
and information on both intra-operative and post-operative 
complications was collected electronically between Janu-
ary 2010 and October 2012.
Result On analysis of a total of 11,885 patients, the overall 
complication and stone-free rates were found to be 7.4 and 
85.6 %, respectively. The intra-operative and post-operative 
complication rates were 4.2 and 2.6 %, respectively, and in 
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(SFR) compared to shockwave lithotripsy (SWL), and lower 
complication rate compared to percutaneous nephrolithotomy 
(PNL) [1]. Most important complications of ureterorenoscopy 
are up-migration [1, 2] of stones, higher retreatment rates [1] 
due to incompletely removed stones (specifically in larger 
stones), and damage to the ureter [1–3] (from minor mucosal 
damage to avulsion) as a consequence of access sheath place-
ment or difficulties with negotiating the ureter and rarely due 
to repetitive in and out movement of instruments.
Most recent guidelines [4] state that the overall compli-
cation rate after URS is 9–25 %. Most complications are 
minor and do not require intervention, and ureteral avul-
sion and strictures are rare (<1 %). There is no statement 
on classification of complications by the EAU. In the lit-
erature, several classification scoring systems can be found, 
such as the Clavien–Dindo [5, 6] classification system, the 
Satava [7] classification system, and the PULS [8] classifi-
cation system. The Clavien–Dindo classification system is 
the most widely used scoring of complications in surgical 
procedures. However, both the Satava and PULS scoring 
systems are URS specific.
The Clinical Research Office of the Endourological 
Society (CROES) URS Global Study was set up to assess 
the indications for URS and its treatment outcomes. Impor-
tant aspects of these outcomes were the nature and severity 
of complications. In this study, we describe the intra-opera-
tive and post-operative complications associated with URS 
treatment from the CROES database.
Methods
The CROES URS Global Study consists of 11,885 patients 
at 114 centres in 32 countries. All these 114 centres used 
collected data electronically through an internet website 
(www.croesoffice.org), by which data were encrypted and 
stored in a central database at the CROES office. This data-
base includes both intra- and post-operative complications 
which were collected between January 2010 and Octo-
ber 2012. Details on data collection have been previously 
described elsewhere [9].
The location of these stones was ureteric (n = 8676, 
73 %) and renal (n = 1852, 15.6 %), and the majority of 
ureteric stones were in the distal ureter (42 %).
Complications
During the procedure, a standardized case report form 
(CRF) was used to collect details of any complication, 
which included information on the relationship of this 
specific event with the type of stone treatment. To define 
intra-operative complications, all predefined categories 
(uneventful, bleeding, ureteral perforation, failed access, 
conversions, and avulsion) were used as dichotomous var-
iables (either having, or not having that specific compli-
cation), which allowed more than one option at the same 
time. Complications that could not be registered using any 
of the predefined categories could be classified as ‘other’. 
The free text that was captured with the ‘other’ option was 
further categorized with data mining. This categorization 
was based on URS-related complications known from 
the literature and included stone migration (proximal or 
extraureteral), mucosal injury, inability to reach a stone, 
and malfunction of instruments [7]. Descriptions that did 
not match any of these categories were examined manu-
ally and were classified as suspicious of tumour, impacted 
stones, encrusted stent, infection related, complications 
not directly related to URS or undefined complications.
After the procedure, the standardized Clavien–Dindo 
scoring system for surgical procedures [5, 6] was used. 
Post-operative complications were classified using the 
predefined categories: bleeding, fever, urinary tract infec-
tion (UTI), pulmonary embolism, cerebro-vascular acci-
dent (CVA), sepsis, acute abdomen, or acute myocardial 
infarction (AMI). Again, the option ‘other’ was available, 
in which the possibility was given to describe the compli-
cation in free text. The free text was categorized with data 
mining into one of the predefined variables, or into an addi-
tional category: pain, urinary retention, stent misplacement, 
nausea and vomiting, respiratory, or allergic reaction. The 
advantage of using the Clavien–Dindo scoring system is 
that in addition to the nature of the complications, it also 
covers grades of severity of these complications.
Statistical analyses
We calculated the actual numbers and percentages of com-
plications. Analyses on consequences were performed with 
a simplified dichotomous variable described as ‘having’ or 
‘not having’ complications and were subdivided into ‘intra- 
and post-operative complications’ ranging from ‘minor’ to 
‘major’ complications.
All analyses were performed using STATA version 13, 
StataCorp LP, College Station, USA (www.stata.com).
Results
Out of 11,885 patients, 874 (7.4 %) had a complication, 
with a stone-free rate (SFR) of 85.6 %. Table 1 shows 
descriptive information of patients with and without com-
plications. For 18 (0.2 %) patients, no information was 
available regarding complications. In Table 2, the nature of 
these complications is listed.
Combining information on intra- and post-oper-
ative complications 55 (0.5 %) had both intra- and 
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Table 1  Descriptive 
information on the CROES 
URS Global study
Patients with complications
N = 874
Patients without complications
N = 10,993
Pre-operative characteristics
Age 51.7 (16.3) 48.4 (15.8)
Gender
 Male 556 (63.7) 7145 (65.0)
 Female 317 (36.3) 3842 (35.0)
BMI 26.7 (5.2) 27.0 (5.4)
Comorbidity
 CVD (including DM) 357 (40.9) 3233 (29.4)
 Prednisone 14 (1.6) 92 (0.9)
 Crohn’s disease 8 (0.9) 51 (0.5)
ASA
 I 324 (39.3) 5672 (55.4)
 II 356 (43.2) 3635 (35.5)
 III 137 (16.6) 884 (8.6)
 IV 7 (0.9) 56 (0.6)
Stone location
 Ureteral stones 209 (62.9) 8068 (73.4)
 Renal stones 550 (23.9) 1597 (14.5)
 Combined procedure 83 (9.5) 975 (8.9)
Previous stone treatment 456 (52.2) 4482 (40.8)
Congenital abnormalities
 Horse shoe 5 (0.6) 40 (0.4)
 Malrotation 1 (0.1) 16 (0.2)
 Ectopic 5 (0.6) 23 (0.2)
 Solitary kidney 38 (4.4) 274 (2.5)
Pre-operative stent placement 194 (22.3) 1985 (18.1)
Intra-operative characteristics
Operation time (min) 50 (33–75) 40 (25–60)
URS type
 Semi rigid 562 (64.5) 8204 (74.9)
 Flexible 174 (20.0) 1607 (14.7)
 Both 135 (15.5) 1138 (10.4)
Antibiotics 775 (89.3) 9019 (83.0)
Access*
 Balloon 72 (8.2) 1505 (13.7)
 Access Sheath 252 (28.8) 2011 (18.3)
 Guidewire 722 (82.6) 8475 (77.2)
 Other 20 (2.3) 264 (2.4)
Fragmentation device
 US 25 (2.9) 121 (1.1)
 Laser 413 (47.5) 5500 (50.2)
 Pneumatic 180 (20.7) 3456 (31.5)
 EHL 5 (0.6) 29 (0.3)
 Other 4 (0.5) 210 (1.9)
 None 242 (27.9) 1679 (15.3)
Post-operative characteristics
Retreatment including readmission 407 (46.6) 1490 (13.6)
SFR (treated area) 514 (59.8) 9682 (89.9)
LOHS (days) 2 (1–4) 1 (1–2)
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post-operative complications with 507 (4.2 %) and 311 
(2.6 %) having isolated intra-operative and post-operative 
complications, respectively. Figure 1 shows the sever-
ity scores of all post-operative complications. Due to the 
nature of the intra-operative complication registration, 
the severity could not be elicited for the intra-operative 
complications. The vast majority of lower grades (I–II) 
of the Clavien classification scores were related to bleed-
ing, fever, urinary tract infection (UTI), and pain. Events 
with Clavien grade III or IV were related to sepsis, stent 
misplacement, urinary retention, or complications from 
the ‘other’ category. The higher Clavien scores (IVA and 
IVB) that were scored post-operatively were scored in 
Australia, Chile, Czech Republic, Egypt, Israel, Japan, 
USA, and The Netherlands. There were no major differ-
ences found in severity of complications between conti-
nents (comparing Europe, Asia, North America, Africa, 
Oceania, and South America). Specifically, there were 
no differences in the higher Clavien scores. The only dif-
ference was that Europe, Oceania, and Africa had more 
grade 2 scores compared to Asia, North America, and 
South America, which had more grade 1 scores. Neither 
was there any difference in complications between dif-
ferent world economies (on comparing developed region 
G7, non-G7, BRIC, MIKT, G20 and the developing 
regions of the world).
As shown in Fig. 1, a total of 5 patients (0.04 %) died 
post-operatively during the 3-month follow-up period. 
Causes of death were described as fatal pulmonary embo-
lism, sepsis, cardiac dysrhythmia, cardiac-related death and 
finally a case of acute bronchopneumonia and multi-organ 
failure. There were no intra-operative deaths reported from 
this worldwide series.
The pre- and post-operative stenting rates were 18.2 and 
81 % for patients without complications, compared to 22.4 
and 87 % for patients with complications. The median case 
volume per centre for patients without complications was 
higher (n = 155) compared to patients with complications 
(n = 120).
Discussion
Principle findings of the study
In this CROES study, the worldwide complications among 
11,885 patients who underwent URS are presented. The 
most frequent complications were fever, failed procedures 
and bleeding, with a total of five post-operative deaths. 
The overall complication rate (7.4 %) was relatively low 
and acceptable for a mixed cohort of unselected patient 
population.
There were no differences in the overall rates of compli-
cations between different continents and economies (devel-
oped versus developing countries) suggesting that URS 
safety is comparable across the world.
Table 1  continued Patients with complications
N = 874
Patients without complications
N = 10,993
Post-operative stent placement 769 (88.8) 8888 (81.0)
Hospital characteristics
Economy
 Developed region: G7 281 (32.2) 2828 (25.7)
 Developed region: non-G7 286 (32.7) 2776(25.3)
 Emerging region: BRIC 107 (12.2) 2102 (19.1)
 Emerging region: MICT 100 (11.4) 1233 (11.2)
 Emerging region: G20 92 (10.5) 1974 (18.0)
 Developing region 8 (0.9) 81 (0.7)
Continent
 Africa 40 (4.6) 397 (3.6)
 Asia 231 (26.4) 4478 (40.7)
 Europe 495 (56.6) 4721 (42.9)
 North America 65 (7.4) 776 (7.1)
 Oceania 6 (0.7) 53 (0.5)
 South America 37 (4.2) 569 (5.2)
Case volume 4.8 (4.2–5.3) 5.0 (4.4–5.9)
Data are n (%) of patients for whom data were available. Percentages exclude missing values from denomi-
nators
* More than one option allowed
679World J Urol (2017) 35:675–681 
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Classification of URS complications
One of the reasons for a low complication rate might be 
a slight selection bias for these patients who might be fit-
ter compared to those receiving other forms of treatment. 
Another potential reason is the use of Clavien–Dindo clas-
sification system. Although the use of the Clavien–Dindo 
classification system for intra-operative complications is 
widely accepted in surgical disciplines, this may not be 
the best suitable scoring system for URS treatment. For 
this reason, the Satava classification system as proposed 
by Tepeler et al. [7] which is used in minimally invasive 
procedures might be better suited. This classification sys-
tem describes complications that are URS specific, such 
as mucosal damage. Another proposed URS-specific clas-
sification system is the Post-Ureteroscopic Lesion Scale 
(PULS) [8]. In the present study, the intra-operative com-
plications were classified with predefined categories cov-
ering topics of the Satava and PULS scoring system, and 
the post-operative complications were classified by the Cla-
vien–Dindo system. As this study is a registry representing 
real-life situations, we chose to use the more general Cla-
vien–Dindo classification system as it is used by majority 
of the centres worldwide.
Meaning and weakness of the study
One may question if the present manuscript has added 
value within the perspective of previous (large) single-cen-
tre studies, systematic reviews, and meta-analyses. Since 
this is not only the largest URS database, but also a data-
base representing, prospectively collected data in a struc-
tured database resulting in homogenous data collection, 
this study provides added value to our insights into global 
outcomes of URS procedures.
A major limitation of the study is the small number of 
complications. Consequently, comparison of outcomes of 
patients with and without complications cannot be sup-
ported by statistical tests for differences. In general, when 
small groups (rare case disease) are to be compared, tech-
niques as used case–control analyses are more suitable 
[10]. Hence, no matter how large the database, the percent-
age of cases matters.
Another possible limitation is linked to the Clavien–Dindo 
classifications system, and we may have suffered underre-
porting in minor self-limiting complications as described by 
Ibrahim [2]. One of these underreported self-limiting com-
plications may be mucosal damage, and there is some debate 
whether or not mucosal damage is simply part of the proce-
dure, or a complication worth mentioning and grading [8, 
11]. Reasons for procedure-related mucosal damage may be 
the repetitive in and out movement of instruments, but also 
Table 2  Descriptive information on intra- and post-operative compli-
cations
Number %
Intra-operative complication
Bleeding 167 1.41
Perforation 124 1.05
Failed access 198 1.67
Conversions 19 0.16
Other 100 0.84
Mucosal injury 15 0.13
Tumour (incidental) 7 0.06
Migration 15 0.13
Impacted stone 4 0.03
Encrusted stent 7 0.06
Infection 8 0.07
Complication NOT by URS 8 0.07
Undefined 36 0.30
Post-operative complication
Bleeding 54 0.45
Fever 204 1.72
UTI 113 0.95
Pulmonary embolism 2 0.02
CVA 1 0.01
Sepsis 36 0.30
Acute abdomen 5 0.04
AMI 1 0.01
Pain 39 0.33
Urinary retention 13 0.11
Stent misplacement 12 0.10
Nausea and vomiting 3 0.03
Respiratory 5 0.04
Allergy 5 0.04
Other 17 0.15
0 10 20 30 40 50 60 70 80 90 100
Bleeding
Fever
UTI
Lung embolism
CVA
Sepsis
Acute abdomen
AMI
Pain
Urinary retenon
Stent placement
Nausea and voming
Respiratory
Allergy
Other
I
II
IIIA
IIIB
IVA
IVB
V
Fig. 1  Clavien score by type of post-operative complication
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inappropriate use of instruments (for example, basketing) 
can be debated. Another underreported complication may be 
haematuria [2], which is not well reported in our study. This 
could well be a natural self-limiting part of the procedure 
rather than a complication. Also the use of information from 
the ‘other’ category might have been underreported due to the 
way of collecting this information. Similarly, up-migration or 
retropulsion of stone may not be a complication in itself but 
increases the total operative time or potentially the need for 
further treatment of this stone at a later date.
In our study, we have used predefined categories and 
highly frequent mentioned events as categories of com-
plications. However, the complications that do not hap-
pen very often, or that users may be unlikely to present as 
complications, like those described in the manufacturer and 
user facility device experience (MAUDE) database, such as 
locked deflection, which is a rare case technical complica-
tion may not be captured [12]. This may also be the case 
for emergency ureterorenoscopy [13], as this was only per-
formed in some but not all reporting centres. Unfortunately, 
information on elective or emergency procedures was not 
captured in the CROES URS Global study.
Areas of future research
To put URS-related complications into perspective, we 
can compare the outcomes with PNL or SWL. One of the 
advantages of SWL is the possibility to perform a proce-
dure without anaesthesia and without any invasiveness into 
the human body [4]. Infection-related complications with 
URS may be reduced using disposable material (scopes, 
laser-tips, baskets); however, its invasive nature unequivo-
cally is related to potential infectious complications. 
For the same reason, PNL has higher complication rates 
(CROES PCNL = 20.5 %) [14]. More understanding on 
higher complication rates for pre-stented patients is needed, 
as it might simply be a reflection of the complexity of the 
case rather than being related to the stent in itself.
For stone and patient demographics, apart from com-
paring outcomes with all treatment types, it would also be 
ideal to standardize and predefine the treatment decisions, 
which vary widely amongst different healthcare setups 
worldwide. Only when this is achieved, we can truly com-
pare outcomes and define complications, which are truly 
accepted benchmark worldwide.
Conclusions
Ureterorenoscopy is a safe and effective procedure for 
treatment of stones, the outcomes of which are broadly 
comparable in different parts of the world for similar 
patient and stone demographics.
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Appendix: Clavien classification of surgical 
complications
I. Any deviation from the normal post-operative course 
without the need for pharmacological treatment or sur-
gical, endoscopic and radiological interventions.
II. Requiring pharmacological treatment with drugs other 
than such allowed for grade I complications.
*Blood transfusions and total parenteral nutrition are 
also included.
III. Requiring surgical, endoscopic, or radiological inter-
vention
IIIA. Intervention not under general anaesthesia
IIIB. Intervention under general anaesthesia
IV. Life-threatening complication (including CNS compli-
cations)‡ requiring IC/ICU-management
IVA. Single organ dysfunction (including dialysis)
IVB. Multi organ dysfunction
V. Death of a patient
*D: If the patients suffer from a complication at the time 
of discharge, the suffix ‘d’ (for ‘disability’) is added to the 
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respective grade of complication. This label indicates the 
need for a follow-up to fully evaluate the complication.
Modified Clavien–Dindo scoring system [5, 6].
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